WARRANTS TO PURCHASE COMMON STOCK

6 Months Ended

Jun. 30, 2025

NOTE 14 – WARRANTS TO PURCHASE COMMON STOCK

The following table summarizes information with respect to outstanding warrants to purchase common stock of the Company at June 30, 2025:

Exercise		Number		Expiration
Price		Outstanding		Date
$	1,056.00		4,585	April 2029
$	1,056.00		2,782	April 2029
$	1,056.00		2,172	April 2029
$	1,056.00		10,884	April 2029
$	1,600.00		36	October 2028
$	2,720.00		5,758	December 2028
$	3,200.00		22	August 2028
			26,239

During the six months ended June 30, 2025, 13,666; 5,758 (as the Company received FDA acceptance of our NDA filing), and 1 warrants with an exercise price of $1,056, $1,776 and $364,800, respectively, expired.

During the six months ended June 30, 2024, 33,841 prefunded common warrants were exercised.